Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Epizyme to Participate in Upcoming Investor Conferences

Posted by fidest press agency su sabato, 1 settembre 2018

New York. Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced that management will present at the following upcoming investor conferences: Citi’s 13th Annual Biotech Conference in Boston – Panel discussion at 3:15 p.m. ET on Wednesday, September 5, 2018.
Morgan Stanley’s 16th Annual Global Healthcare Conference in New York City – Fireside chat at 2:50 p.m. ET on Wednesday, September 12, 2018
Leerink Partners 2018 Rare Disease & Oncology Roundtable in New York City – Fireside chat at 10:00 a.m. ET on Wednesday, October 3, 2018
To access a live webcast of these presentations, please visit the Events & Presentations page within the Investor section of the company’s website at A replay of each webcast will be available on the Epizyme website for 60 days following the event.
Epizyme, Inc. is a clinical-stage biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through novel epigenetic medicines. Epizyme is broadly developing its lead product candidate, tazemetostat, a first-in-class EZH2 inhibitor, with studies underway in both solid tumors and hematological malignancies, as a monotherapy and combination therapy in relapsed and front-line disease. The company is also developing a novel G9a program with its next development candidate, EZM8266, which is targeting sickle cell disease. By focusing on the genetic drivers of disease, Epizyme’s science seeks to match targeted medicines with the patients who need them. For more information, visit


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: